Close

Fulcrum Therapeutics Presents Data for Potential FSHD Biomarker and Clinical Outcome Assessments at 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference

Go back to Fulcrum Therapeutics Presents Data for Potential FSHD Biomarker and Clinical Outcome Assessments at 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference
(NASDAQ: FULC) Delayed: 7.10 -0.18 (2.47%)
Previous Close $7.28    52 Week High
Open $7.07    52 Week Low
Day High $7.18    P/E N/A 
Day Low $6.85    EPS
Volume 164,754